BioGend Therapeutics Market Cap

BioGend Therapeutics has a market cap or net worth of 3.61 billion as of April 28, 2026. Its market cap has decreased by -8.01% in one year.

Market Cap

3.61B

Enterprise Value

3.11B

Revenue

222.34M

Ranking

n/a

PE Ratio

n/a

Stock Price

29.05

Market Cap Chart

Since June 18, 2019, BioGend Therapeutics's market cap has increased from 2.71B to 3.61B, an increase of 32.87%. That is a compound annual growth rate of 4.23%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	3.61B	-24.48%
Dec 31, 2025	4.78B	14.21%
Dec 31, 2024	4.18B	-11.18%
Dec 29, 2023	4.71B	109.50%
Dec 30, 2022	2.25B	-18.50%
Dec 30, 2021	2.76B	-22.86%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Energenesis Biomedical CO.,LTD.	3.70B
Sagittarius Life Science	3.90B
Shine-On BioMedical	3.30B
Intech Biopharm	3.23B
Formosa Pharmaceuticals	4.05B
Genovate Biotechnology	3.19B
SYN-TECH Chem. & Pharm.	3.15B
OBI Pharma	4.14B

Market Cap Rankings